X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (80) 80
humans (76) 76
female (62) 62
male (59) 59
middle aged (57) 57
gastroenterology & hepatology (56) 56
aged (40) 40
adult (31) 31
hepatocellular carcinoma (30) 30
cirrhosis (28) 28
liver cirrhosis (26) 26
liver cirrhosis - complications (25) 25
retrospective studies (24) 24
liver (20) 20
liver cancer (20) 20
hepatitis c (18) 18
life sciences (18) 18
risk factors (18) 18
hepatoma (17) 17
cancer (16) 16
gastroenterology and hepatology (16) 16
liver cirrhosis - virology (16) 16
prospective studies (16) 16
prognosis (15) 15
biopsy (14) 14
carcinoma, hepatocellular - genetics (14) 14
liver neoplasms - genetics (14) 14
carcinoma, hepatocellular - surgery (13) 13
human health and pathology (13) 13
liver neoplasms - surgery (13) 13
patients (13) 13
aged, 80 and over (12) 12
carcinoma, hepatocellular - pathology (12) 12
hepatitis c - complications (12) 12
survival (12) 12
carcinoma, hepatocellular - diagnosis (11) 11
carcinoma, hepatocellular - epidemiology (11) 11
carcinoma, hepatocellular - etiology (11) 11
disease (11) 11
follow-up studies (11) 11
hepatitis c virus (11) 11
hepatitis c, chronic - complications (11) 11
liver neoplasms - diagnosis (11) 11
liver neoplasms - epidemiology (11) 11
liver neoplasms - etiology (11) 11
liver neoplasms - mortality (11) 11
liver neoplasms - pathology (11) 11
risk-factors (11) 11
treatment outcome (11) 11
carcinoma, hepatocellular - mortality (10) 10
fibrosis (10) 10
liver - pathology (10) 10
abridged index medicus (9) 9
genotype (9) 9
hepatitis (9) 9
multivariate analysis (9) 9
oncology (9) 9
risk (9) 9
analysis (8) 8
carcinoma, hepatocellular - complications (8) 8
carcinoma, hepatocellular - therapy (8) 8
chronic hepatitis-c (8) 8
epidemiology (8) 8
expression (8) 8
incidence (8) 8
kaplan-meier estimate (8) 8
liver cirrhosis, alcoholic - complications (8) 8
liver neoplasms - complications (8) 8
liver neoplasms - therapy (8) 8
prevalence (8) 8
recurrence (8) 8
therapy (8) 8
diagnosis (7) 7
hepatocellular-carcinoma (7) 7
hépatology and gastroenterology (7) 7
liver cirrhosis - mortality (7) 7
liver cirrhosis - pathology (7) 7
liver diseases (7) 7
management (7) 7
radiofrequency ablation (7) 7
survival rate (7) 7
care and treatment (6) 6
elasticity (6) 6
france - epidemiology (6) 6
hepatitis b (6) 6
hepatitis b virus (6) 6
hepatology (6) 6
medical research (6) 6
natural-history (6) 6
screening (6) 6
transient elastography (6) 6
tumors (6) 6
ultrasonography (6) 6
case-control studies (5) 5
cohort studies (5) 5
digestive system diseases (5) 5
france (5) 5
genetic aspects (5) 5
health aspects (5) 5
interferon (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Transfusion clinique et biologique, ISSN 1246-7820, 09/2019, Volume 26, Issue 3, p. S96
Les patients atteints d'hemochromatose, via leurs associations, ont alerte les tutelles sur les difficultes de leur prise en charge du fait de la diminution... 
Journal Article
Hepato-Gastro et Oncologie Digestive, ISSN 2115-3310, 05/2018, Volume 25, Issue 5, pp. 426 - 435
Journal Article
by Vilgrain, Valérie and Pereira, Helena and Assenat, Eric and Guiu, Boris and Ilonca, Alina Diana and Ilonca, Alina D and Pageaux, Georges-Philippe and Sibert, Annie and Bouattour, Mohamed and Lebtahi, Rachida and Allaham, Wassim and Barraud, Hélène and Laurent, Valérie and Mathias, Elodie and Bronowicki, Jean-Pierre and Tasu, Jean-Pierre and Perdrisot, Rémy and Silvain, Christine and Gerolami, René and Mundler, Olivier and Seitz, Jean-Francois and Vidal, Vincent and Aubé, Christophe and Oberti, Frédéric and Couturier, Olivier and Brenot-Rossi, Isabelle and Raoul, Jean-Luc and Sarran, Anthony and Costentin, Charlotte and Itti, Emmanuel and Luciani, Alain and Adam, René and Lewin, Maïté and Samuel, Didier and Ronot, Maxime and Dinut, Aurelia and Castera, Laurent and Chatellier, Gilles and Delhom - Christol, Elisabeth and Lonjon, Julie and Abdel-Rehim, Mohamed and Dieudonné, Arnaud and Bazin, Christophe and Chagneau-Derrode, Carine and Borentain, Patrick and Bouvier, Antoine and Vervueren, Laurent and Chalaye, Julia and Kobeiter, Hicham and Edeline, Julien and Garin, Etienne and Rolland, Yan and Archambeaud, Isabelle and Eugene, Thomas and Frampas, Eric and Cassinotto, Christophe and Guyot, Martine and Hiriart, Jean-Baptiste and Lapuyade, Bruno and Vergniol, Julien and Bachellier, Philippe and Detour, Julien and Duclos, Bernard and Greget, Michel and Habersetzer, Francois and Imperiale, Alessio and Merle, Philippe and Rode, Agnès and Morvan, Julie and Nguyen-Khac, Eric and Yzet, Thierry and Baudin, Guillaume and Chevallier, Patrick and Mahamat, Abakar and Piche, Thierry and Razzouk, Micheline and Hillon, Patrick and Loffroy, Romaric and Toubeau, Michel and Vincent, Julie and Barabino, Gabriele and Bouarioua, Nadia and Cuilleron, Muriel and Ecochard, Marie and Prevot-Bitot, Nathalie and Leroy, Vincent and Roux, Julie and Sengel, Christian and Bourcier, Valérie and Ganne-Carrie, Nathalie and Seror, Olivier and Costo, Sylvie and Dao, Thông and Pelage, Jean-Pierre and Dumortier, Jérôme and Giammarile, Francesco and Valette, Pierre-Jean and Ghazzar, Nadia and Pellerin, Olivier and Taieb, Julien and ... and SARAH Trial Grp and SARAH Trial Group
The Lancet Oncology, ISSN 1470-2045, 12/2017, Volume 18, Issue 12, pp. 1624 - 1636
Sorafenib is the recommended treatment for patients with advanced hepatocellular carcinoma. We aimed to compare the efficacy and safety of sorafenib to that of... 
SURVIVAL | THERAPY | ONCOLOGY | COMPETING RISK | TRANSARTERIAL CHEMOEMBOLIZATION | RADIOEMBOLIZATION | QUALITY-OF-LIFE | Niacinamide - analogs & derivatives | Carcinoma, Hepatocellular - mortality | Follow-Up Studies | Humans | Middle Aged | Male | Antineoplastic Agents - administration & dosage | Liver Neoplasms - mortality | Dose-Response Relationship, Drug | Microspheres | Carcinoma, Hepatocellular - drug therapy | Antineoplastic Agents - adverse effects | Neoplasm Invasiveness - pathology | Phenylurea Compounds - adverse effects | Adult | Female | Liver Neoplasms - pathology | Yttrium Radioisotopes - therapeutic use | Radiotherapy Dosage | Drug Administration Schedule | Administration, Oral | Brachytherapy - methods | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Niacinamide - adverse effects | Carcinoma, Hepatocellular - radiotherapy | Treatment Outcome | Niacinamide - administration & dosage | Disease-Free Survival | Phenylurea Compounds - administration & dosage | Liver Neoplasms - radiotherapy | Sorafenib | Carcinoma, Hepatocellular - pathology | Survival Analysis | Aged | Neoplasm Staging | Rare earth metals | Antimitotic agents | Product development | Hepatoma | Comparative analysis | Radiotherapy | Antineoplastic agents | Index Medicus | Life Sciences | Liver Neoplasms/drug therapy | Phenylurea Compounds/administration & dosage | Yttrium Radioisotopes/therapeutic use | Niacinamide/analogs & derivatives | Carcinoma, Hepatocellular/radiotherapy | Carcinoma, Hepatocellular/drug therapy | Cancer
Journal Article
European Journal of Gastroenterology & Hepatology, ISSN 0954-691X, 01/2013, Volume 25, Issue 1, pp. 94 - 98
Journal Article
Revue du Praticien, ISSN 0035-2640, 02/2013, Volume 63, Issue 2, pp. 222 - 225
Journal Article
Journal Article
Gastroenterology, ISSN 0016-5085, 2008, Volume 134, Issue 1, pp. 102 - 110
Journal Article
Journal Article
Journal of gastroenterology and hepatology, ISSN 0815-9319, 06/2019
The prognostic value of transient elastography (TE) in cirrhotic patients with hepatocellular carcinoma (HCC) treated by percutaneous radiofrequency ablation... 
Index Medicus
Journal Article
Journal of Viral Hepatitis, ISSN 1352-0504, 03/2019, Volume 26, Issue 3, pp. 384 - 396
Worldwide, hepatocellular carcinoma ( HCC ) occurs mainly in Asian patients with hepatitis B virus ( HBV ) infection. This study aimed to decipher the... 
viral cirrhosis | carcinogenesis | prognosis | ANRS CO | 12 CirVir | risk score | ANRS CO12 CirVir | FIBROSIS | ENTECAVIR | INFECTIOUS DISEASES | COST-EFFECTIVENESS | MANAGEMENT | CAUCASIANS | RISK SCORES | OBESITY | VIROLOGY | SURVEILLANCE PROGRAM | LIVER | GASTROENTEROLOGY & HEPATOLOGY | TENOFOVIR | Automobile drivers | Antiviral agents | Analysis | Hepatoma | Hepatitis C | Health aspects | Liver cirrhosis | Risk factors | Hepatitis B
Journal Article
European Journal of Gastroenterology & Hepatology, ISSN 0954-691X, 05/2018, Volume 30, Issue 10, pp. 1216 - 1223
Journal Article